KM Research Hub

LITERATURE

原始候选快照

v3 复核前的候选池,完整保留,仅供查看,不会自动重新处理。 共 7004 篇。

导出 CSV
论文标识日期入排置信度入排依据KM 状态
INTEGRATE II: randomised phase III controlled trials of regorafenib containing regimens versus standard of care in refractory Advanced Gastro-Oesophageal Cancer (AGOC): a study by the Australasian Gastro-Intestinal Trials Group (AGITG).BMC CancerPMID 36814222PMC99456182023-Feb-220.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
A phase 2/3 study of S-217622 in participants with SARS-CoV-2 infection (Phase 3 part).Medicine (Baltimore)PMID 36827007PMC99493722023-Feb-220.98未发现恶性肿瘤人群证据。待处理
Effect of Atogepant for Preventive Migraine Treatment on Patient-Reported Outcomes in the Randomized, Double-blind, Phase 3 ADVANCE Trial.NeurologyPMID 36396451PMC99842202023-Feb-210.98未发现恶性肿瘤人群证据。待处理
Aspirin Discontinuation at 24 to 28 Weeks' Gestation in Pregnancies at High Risk of Preterm Preeclampsia: A Randomized Clinical Trial.JAMAPMID 36809321PMC99450692023-Feb-210.98未发现恶性肿瘤人群证据。待处理
BOHEMIA: Broad One Health Endectocide-based Malaria Intervention in Africa-a phase III cluster-randomized, open-label, clinical trial to study the safety and efficacy of ivermectin mass drug administration to reduce malaria transmission in two African settings.TrialsPMID 36810194PMC99420132023-Feb-210.98未发现恶性肿瘤人群证据。待处理
Durvalumab With or Without Tremelimumab in Combination With Chemotherapy as First-Line Therapy for Metastatic Non-Small-Cell Lung Cancer: The Phase III POSEIDON Study.J Clin OncolPMID 36327426PMC99370972023-Feb-200.96明确的 Phase III/IIIb/II-III 随机肿瘤药物试验,且报告 time-to-event 结局。待处理
Mepitel Film for the Prevention of Acute Radiation Dermatitis in Breast Cancer: A Randomized Multicenter Open-Label Phase III Trial.J Clin OncolPMID 36493331无 PMCID2023-Feb-200.85This is a Phase III randomized trial in human oncology (breast cancer) with original results. However, it is excluded because the intervention (Mepitel Film) is not a drug (it's a silicone film/device for preventing radiation dermatitis), and the primary endpoint is not a time-to-event efficacy endpoint but an incidence rate of a toxicity (radiation dermatitis). No drug intervention or time-to-event endpoint is present.待处理
Efficacy and safety of Obex® in overweight and obese subjects: a randomised, double-blind, placebo-controlled clinical trial.BMC Complement Med TherPMID 36804035PMC99404322023-Feb-200.98未发现恶性肿瘤人群证据。待处理
Zuranolone in Major Depressive Disorder: Results From MOUNTAIN-A Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial.J Clin PsychiatryPMID 36811520无 PMCID2023-Feb-200.98未发现恶性肿瘤人群证据。待处理
Sodium bicarbonate for kidney transplant recipients with metabolic acidosis in Switzerland: a multicentre, randomised, single-blind, placebo-controlled, phase 3 trial.LancetPMID 36708734无 PMCID2023-Feb-180.98未发现恶性肿瘤人群证据。待处理
Breast-Conserving Surgery with or without Irradiation in Early Breast Cancer.N Engl J MedPMID 36791159无 PMCID2023-Feb-160.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older Adults.N Engl J MedPMID 36791160无 PMCID2023-Feb-160.98未发现恶性肿瘤人群证据。待处理
Evaluation of BNT162b2 Covid-19 Vaccine in Children Younger than 5 Years of Age.N Engl J MedPMID 36791162PMC99479232023-Feb-160.98未发现恶性肿瘤人群证据。待处理
First-line nivolumab plus chemotherapy vs chemotherapy in patients with advanced gastric, gastroesophageal junction and esophageal adenocarcinoma: CheckMate 649 Chinese subgroup analysis.Int J CancerPMID 36121651PMC100924932023-Feb-150.96属于事后亚组、二次、生活质量或卫生经济学分析,不作为原始随机试验结果纳入。待处理
A New Option for Pain Prevention Using a Therapeutic Virtual Reality Solution for Bone Marrow Biopsy (REVEH Trial): Open-Label, Randomized, Multicenter, Phase 3 Study.J Med Internet ResPMID 36790852PMC99789872023-Feb-150.95Study meets oncology, human, randomized, and phase criteria, but lacks required drug intervention and time-to-event endpoint; endpoint is pain intensity (VAS), not survival or progression.待处理
Depatuxizumab mafodotin in EGFR-amplified newly diagnosed glioblastoma: A phase III randomized clinical trial.Neuro OncolPMID 35849035PMC99257122023-Feb-140.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Zanubrutinib Versus Ibrutinib in Relapsed/Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma: Interim Analysis of a Randomized Phase III Trial.J Clin OncolPMID 36395435PMC99286832023-Feb-100.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
A randomized phase 3 trial of the immunogenicity and safety of coadministration of a live-attenuated tetravalent dengue vaccine (TAK-003) and an inactivated hepatitis a (HAV) virus vaccine in a dengue non-endemic country.VaccinePMID 36681529无 PMCID2023-Feb-100.98未发现恶性肿瘤人群证据。待处理
Secukinumab long-term efficacy and safety in psoriasis through to year 5 of treatment: results of a randomized extension of the phase III ERASURE and FIXTURE trials.Br J DermatolPMID 36763857无 PMCID2023-Feb-100.98未发现恶性肿瘤人群证据。待处理
Efficacy of downtitration or treatment withdrawal compared with continuous dosing after successful treatment with baricitinib in patients with moderate-to-severe atopic dermatitis in a randomized substudy from the long-term extension study BREEZE-AD3.Br J DermatolPMID 36763879无 PMCID2023-Feb-100.98未发现恶性肿瘤人群证据。待处理
Lobar or Sublobar Resection for Peripheral Stage IA Non-Small-Cell Lung Cancer.N Engl J MedPMID 36780674PMC100366052023-Feb-090.90The study is a Phase III randomized trial for human NSCLC with time-to-event endpoints (DFS, OS), but the intervention is surgical (sublobar resection vs lobar resection), not a drug-containing intervention. Drug intervention is a required criterion.待处理
Transfusing Convalescent Plasma as Post-Exposure Prophylaxis Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Double-Blinded, Phase 2 Randomized, Controlled Trial.Clin Infect DisPMID 35579509PMC91291912023-Feb-080.98未发现恶性肿瘤人群证据。待处理
Clinical Safety Experience of TAK-003 for Dengue Fever: A New Tetravalent Live Attenuated Vaccine Candidate.Clin Infect DisPMID 35639602PMC99074832023-Feb-080.98未发现恶性肿瘤人群证据。待处理
Validation of a Health-Related Quality of Life Questionnaire in Patients With Recurrent Clostridioides difficile Infection in ECOSPOR III, a Phase 3 Randomized Trial.Clin Infect DisPMID 35789381无 PMCID2023-Feb-080.98未发现恶性肿瘤人群证据。待处理
Tenofovir Disoproxil Fumarate/Emtricitabine and Baricitinib for Patients at High Risk of Severe Coronavirus Disease 2019: The PANCOVID Randomized Clinical Trial.Clin Infect DisPMID 35906838PMC93846012023-Feb-080.98未发现恶性肿瘤人群证据。待处理
Rifapentine With and Without Moxifloxacin for Pulmonary Tuberculosis in People With Human Immunodeficiency Virus (S31/A5349).Clin Infect DisPMID 36041016PMC101694272023-Feb-080.98未发现恶性肿瘤人群证据。待处理
Paromomycin and Miltefosine Combination as an Alternative to Treat Patients With Visceral Leishmaniasis in Eastern Africa: A Randomized, Controlled, Multicountry Trial.Clin Infect DisPMID 36164254PMC99075392023-Feb-080.98未发现恶性肿瘤人群证据。待处理
Safety and Efficacy of the NVX-CoV2373 Coronavirus Disease 2019 Vaccine at Completion of the Placebo-Controlled Phase of a Randomized Controlled Trial.Clin Infect DisPMID 36210481PMC96196352023-Feb-080.98未发现恶性肿瘤人群证据。待处理
Radiosurgery of limited brain metastases from primary solid tumor: results of the randomized phase III trial (NCT02355613) comparing treatments executed with a specialized or a C-arm linac-based platform.Radiat OncolPMID 36750848PMC99069372023-Feb-070.85The trial meets criteria for oncology, human, randomized, phase III, time-to-event endpoints, and original results, but it lacks the required drug-containing intervention. The comparison is between two radiation delivery technologies, not a drug.待处理
PARa-aOrtic LymphAdenectomy in locally advanced cervical cancer (PAROLA trial): a GINECO, ENGOT, and GCIG study.Int J Gynecol CancerPMID 36717163无 PMCID2023-Feb-060.95The study is a randomized Phase III trial in human oncology with a time-to-event primary endpoint, but it does not describe a drug-containing intervention (it is a surgical and radiotherapy-based trial). Furthermore, it is a protocol abstract, not a report of original results.待处理
Medial retropharyngeal nodal region sparing radiotherapy versus standard radiotherapy in patients with nasopharyngeal carcinoma: open label, non-inferiority, multicentre, randomised, phase 3 trial.BMJPMID 36746459PMC99004702023-Feb-060.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Randomized double-blind, placebo-controlled study of oral gabapentin for prevention of neuropathy in patients receiving paclitaxel.TrialsPMID 36732774PMC98966962023-Feb-030.85The record is a protocol for a Phase III randomized trial investigating a drug intervention for neuropathy prevention in cancer patients. However, it is not an original result report, and its primary endpoint is not a time-to-event oncology efficacy endpoint.待处理
VV116 versus Nirmatrelvir-Ritonavir for Oral Treatment of Covid-19.N Engl J MedPMID 36577095PMC98122892023-Feb-020.98未发现恶性肿瘤人群证据。待处理
Pembrolizumab With or Without Chemotherapy in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Updated Results of the Phase III KEYNOTE-048 Study.J Clin OncolPMID 36219809PMC99020122023-Feb-010.96属于事后亚组、二次、生活质量或卫生经济学分析,不作为原始随机试验结果纳入。待处理
Optimal Treatment Duration of Bevacizumab as Front-Line Therapy for Advanced Ovarian Cancer: AGO-OVAR 17 BOOST/GINECO OV118/ENGOT Ov-15 Open-Label Randomized Phase III Trial.J Clin OncolPMID 36332161无 PMCID2023-Feb-010.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Effectiveness of Adjuvant Pembrolizumab vs High-Dose Interferon or Ipilimumab for Quality-of-Life Outcomes in Patients With Resected Melanoma: A Secondary Analysis of the SWOG S1404 Randomized Clinical Trial.JAMA OncolPMID 36416836PMC96855502023-Feb-010.96属于事后亚组、二次、生活质量或卫生经济学分析,不作为原始随机试验结果纳入。待处理
Efficacy and Safety of Lebrikizumab in Combination With Topical Corticosteroids in Adolescents and Adults With Moderate-to-Severe Atopic Dermatitis: A Randomized Clinical Trial (ADhere).JAMA DermatolPMID 36630140PMC98574392023-Feb-010.98未发现恶性肿瘤人群证据。待处理
Gefitinib Plus Chemotherapy vs Gefitinib Alone in Untreated EGFR-Mutant Non-Small Cell Lung Cancer in Patients With Brain Metastases: The GAP BRAIN Open-Label, Randomized, Multicenter, Phase 3 Study.JAMA Netw OpenPMID 36753281PMC99094982023-Feb-010.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Effect of Epirubicin Plus Paclitaxel vs Epirubicin and Cyclophosphamide Followed by Paclitaxel on Disease-Free Survival Among Patients With Operable ERBB2-Negative and Lymph Node-Positive Breast Cancer: A Randomized Clinical Trial.JAMA Netw OpenPMID 36826820PMC99585292023-Feb-010.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
ePHex: a phase 3, double-blind, placebo-controlled, randomized study to evaluate long-term efficacy and safety of Oxalobacter formigenes in patients with primary hyperoxaluria.Pediatr NephrolPMID 35552824PMC97631412023-Feb0.98未发现恶性肿瘤人群证据。待处理
A phase III randomized, double-blind, placebo-controlled trial of the denosumab biosimilar QL1206 in postmenopausal Chinese women with osteoporosis and high fracture risk.Acta Pharmacol SinPMID 35896694PMC98897412023-Feb0.98未发现恶性肿瘤人群证据。待处理
Opium tincture versus methadone for opioid agonist treatment: a randomized controlled trial.AddictionPMID 35971297无 PMCID2023-Feb0.98未发现恶性肿瘤人群证据。待处理
Standard diametric versus volumetric early tumor shrinkage as a predictor of survival in metastatic colorectal cancer: subgroup findings of the randomized, open-label phase III trial FIRE-3 / AIO KRK-0306.Eur RadiolPMID 35976398PMC98894292023-Feb0.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Japanese subgroup analysis of EV-301: An open-label, randomized phase 3 study to evaluate enfortumab vedotin versus chemotherapy in subjects with previously treated locally advanced or metastatic urothelial carcinoma.Cancer MedPMID 36052536PMC99391462023-Feb0.96属于事后亚组、二次、生活质量或卫生经济学分析,不作为原始随机试验结果纳入。待处理
Results from the IMpower132 China cohort: Atezolizumab plus platinum-based chemotherapy in advanced non-small cell lung cancer.Cancer MedPMID 36052772PMC99391922023-Feb0.96明确的 Phase III/IIIb/II-III 随机肿瘤药物试验,且报告 time-to-event 结局。待处理
Evaluating the efficacy and safety of SpikoGen®, an Advax-CpG55.2-adjuvanted severe acute respiratory syndrome coronavirus 2 spike protein vaccine: a phase 3 randomized placebo-controlled trial.Clin Microbiol InfectPMID 36096430PMC94630772023-Feb0.98未发现恶性肿瘤人群证据。待处理
Recapture and retreatment rates with ixekizumab after withdrawal of therapy in patients with axial spondyloarthritis: results at week 104 from a randomised placebo-controlled withdrawal study.Ann Rheum DisPMID 36100350PMC98873472023-Feb0.98未发现恶性肿瘤人群证据。待处理
The renoprotective effect of esaxerenone independent of blood pressure lowering: a post hoc mediation analysis of the ESAX-DN trial.Hypertens ResPMID 36100672PMC98996882023-Feb0.98未发现恶性肿瘤人群证据。待处理
Inclusion of patients with chronic kidney disease in randomized phase 3 clinical trials in patients with prostate, breast, lung, and colorectal cancer.Cancer MedPMID 36156460PMC99391762023-Feb0.95This record is a methodological analysis of patient exclusion criteria across multiple phase 3 oncology trials, not a report of survival or efficacy outcomes from a specific randomized controlled trial. While the publication metadata indicates it is a Phase III/Randomized Controlled Trial journal article, the content is a survey of trial protocols (ClinicalTrials.gov) focusing on renal exclusion criteria, not trial results. It therefore lacks the required outcome signal (survival, progression, etc.) for inclusion.待处理
Change in pharmacodynamic variables following once-weekly tirzepatide treatment versus dulaglutide in Japanese patients with type 2 diabetes (SURPASS J-mono substudy).Diabetes Obes MetabPMID 36184780PMC100921542023-Feb0.98未发现恶性肿瘤人群证据。待处理